Currently Viewing:
Patient-Centered Oncology Care
Currently Reading
Ian Manners Outlines Pharma's Participation in Providing Financial Assistance for Patients
May 23, 2018
Ian Manners Explains How Vivor Empowers Providers and Financial Navigators
May 03, 2018
Dr Thomas Graf: Personalizing Cancer Care Payment Models
April 16, 2018
Dr Stacey McCullough Discusses Teamwork and Collaboration in Oncology
April 13, 2018
Torrie Fields: Collecting and Using Data Can Better Inform a Patient
April 12, 2018
Dr Thomas Graf Discusses the Effect of Novel Therapies on Private Coverage
April 06, 2018
Kathleen Lokay: Incorporating the Latest Research and Supporting Physicians
April 05, 2018
Dr Stacey McCullough on the Pharmacist's Role in Patient Education
March 29, 2018
Dr Thomas Graf: How the Impact of Novel Therapies Varies Among Stakeholders
March 22, 2018
Jason Harris Highlights National Health Council's Recommendations on Real-World Evidence
March 18, 2018
Ian Manners Explains the Impact of Patient Financial Assistance Programs
March 17, 2018
Dr Thomas Graf on the Impact of New Therapies in Oncology
March 12, 2018
Jason Harris: Improving Patient Understanding and Promoting High-Value Care
March 02, 2018
Dr Brenton Fargnoli on Fixing Issues Physicians Have With EHRs
February 18, 2018
Kathleen Lokay: Implementing Value in Clinical Pathways
February 13, 2018
Jason Harris Discusses the Importance of Real-World Evidence
February 11, 2018
Dr Brenton Fargnoli Explains How Quality Measurement Benchmarks Drive Action
February 09, 2018
Kathleen Lokay on Educating Patients on Treatment Options
January 28, 2018
Dr Brenton Fargnoli Discusses the Creation of a Learning Health System
January 25, 2018

Kathleen Lokay: Clinical Pathways Can Prevent Prior Authorization Delays

Clinical pathways can help providers avoid delays with prior authorization by ensuring that all the necessary information is there, explained Kathleen Lokay, president and CEO of Via Oncology.
 


Clinical pathways can help providers avoid delays with prior authorization by ensuring that all the necessary information is there, explained Kathleen Lokay, president and CEO of Via Oncology.

Transcript

How can pathways programs assist physicians who face prior authorization delays?

The challenge with prior authorization is the idea that oftentimes what your picking for the patient might be the right thing, but it’s all the information that has to be provided that is necessary to get it paid for. So, it’s rarely that the treatment itself is not eligible for prior authorization, but that the information is lacking.

One of the way we try to support folks with clinical pathways is by providing all that clinical information to the staff who actually seek the prior authorization. By getting the right information into the prior authorization into the portal the first time, then the likelihood of getting the prior authorization and having it go through successfully initially is much higher as opposed to finding out a week or a month or 6 months later that you didn’t give all the information and therefore your prior authorization didn’t go through and you’ve got a denial on your hands.

So that’s one of the key ways we see decision support really helping with prior authorization is by providing that critical clinical data.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!